Original Research
Published on 31 Oct 2024
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1436587
- 1,141 views
Type at least 3 characters
1,832 articles
Case Report
Published on 31 Oct 2024
TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1484256
- 986 views
Review
Published on 31 Oct 2024
Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1447001
- 1,977 views
- 1 citation
Original Research
Published on 31 Oct 2024
The identification and correction of pseudohypercalcemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1441851
- 1,242 views
Brief Research Report
Published on 24 Oct 2024
Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1480793
- 846 views
Mini Review
Published on 22 Oct 2024
The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1392653
- 1,395 views
Review
Published on 22 Oct 2024
Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1481950
- 1,674 views
Original Research
Accepted on 21 Oct 2024
Bone marrow involvement in solid tumors -a retrospective observational study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1434709
Original Research
Published on 17 Oct 2024
Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1429221
- 1,362 views
Original Research
Published on 17 Oct 2024
COVID-19 in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a propensity matched analysis (2020-2021)
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446482
- 1,910 views
Editorial
Published on 17 Oct 2024
Editorial: Novelties in acute myeloid leukemia: from biology to clinical applications
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1499272
- 802 views
Methods
Published on 14 Oct 2024
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1458449
- 2,304 views
Systematic Review
Published on 11 Oct 2024
Association of CTLA-4 polymorphisms with hematologic malignancy susceptibility: a meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1467740
- 852 views
Brief Research Report
Published on 09 Oct 2024
Survival outcomes of patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation in Germany: real-world evidence from an administrative database between 2010 and 2019
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1432310
- 1,221 views
Correction
Published on 09 Oct 2024
Corrigendum: Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472773
- 545 views
Original Research
Published on 02 Oct 2024
Experience with luspatercept therapy in patients with transfusion-dependent low-risk myelodysplastic syndromes in real-world clinical practice: exploring the positive effect of combination with erythropoietin alfa
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1398331
- 1,743 views